TAM
RAPT

Tucker Asset Management’s RAPT Therapeutics RAPT Stock Holding History

Tucker Asset Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13
Closed -$1.87K – 1518
2023
Q2 		$1.87K Sell
13
-109
-89% -$17K ﹤0.01% 872
2023
Q1 		$18K Buy
+122
New +$24.7K 0.01% 439

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Tucker Asset Management's RAPT Position: Q3 2023 in Review

Tucker Asset Management sold out of RAPT Therapeutics (RAPT) in Q3 2023, closing a stake of 13 shares — an estimated $1.87K sold.

Tucker Asset Management first reported a position in RAPT in Q1 2023 and held it in 2 quarters. The position peaked at $18K in Q1 2023. 96 funds tracked by Wall St. Rank hold RAPT as of Q3 2023.

  • Tucker Asset Management reported no remaining RAPT Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Tucker Asset Management sold 13 RAPT Therapeutics shares in Q3 2023, an estimated $1.87K.
  • Tucker Asset Management first reported a position in RAPT Therapeutics in Q1 2023 and held it in 2 quarters.
  • Tucker Asset Management's RAPT Therapeutics position peaked at $18K in Q1 2023.
  • 96 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2023.

Based on Tucker Asset Management's 13F filing for Q3 2023, filed 4 Dec 2023.